October 21, 2026Stocks·Bullish·corporate
INmune Bio signs master services agreement with Uniphar for named-patient access to Ebstrocel in Europe, MENA
INmune Bio announced a master services agreement with Uniphar for named-patient access to Ebstrocel in select European and MENA markets.
Detected & updated continuously · Source: Nebula
Story subjects